SEARCH

SEARCH BY CITATION

References

  • Bender, F.C., Whitbeck, J.C., Ponce de Leon, M., Lou, H., Eisenberg, R.J., and Cohen, G.H. (2003) Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry. J Virol 77: 95429552.
  • Berting, A., Fischer, C., Schaefer, S., Garten, W., Klenk, H.D., and Gerlich, W.H. (2000) Hemifusion activity of a chimeric influenza virus hemagglutinin with a putative fusion peptide from hepatitis B virus. Virus Res 68: 3549.
  • Brown, E.L., and Lyles, D.S. (2003) A novel method for analysis of membrane microdomains: vesicular stomatitis virus glycoprotein microdomains change in size during infection, and those outside of budding sites resemble sites of virus budding. Virology 310: 343358.
  • Bruss, V., Hagelstein, J., Gerhardt, E., and Galle, P.R. (1996) Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity. Virology 218: 396399.
  • Campbell, S., Gaus, K., Bittman, R., Jessup, W., Crowe, S., and Mak, J. (2004) The raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated Brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity. J Virol 78: 1055610565.
  • Clejan, S., and Bittman, R. (1985) Rates of amphotericin B and filipin association with sterols. A study of changes in sterol structure and phospholipid composition of vesicles. J Biol Chem 260: 28842889.
  • Codran, A., Royer, C., Jaeck, D., Bastien-Valle, M., Baumert, T.F., Kieny, M.P., et al. (2006) Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis. J Gen Virol 87: 25832593.
  • Gavilanes, F., Gonzalez-Ros, J.M., and Peterson, D.L. (1982) Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins. J Biol Chem 257: 77707777.
  • Glebe, D. (2006) Attachment sites and neutralising epitopes of hepatitis B virus. Minerva Gastroenterol Dietol 52: 321.
  • Glebe, D., and Gerlich, W.H. (2004) Study of the endocytosis and intracellular localization of subviral particles of hepatitis B virus in primary hepatocytes. Methods Mol Med 96: 143151.
  • Glebe, D., and Urban, S. (2007) Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13: 2238.
  • Glebe, D., Aliakbari, M., Krass, P., Knoop, E.V., Valerius, K.P., and Gerlich, W.H. (2003) Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J Virol 77: 95119521.
  • Glebe, D., Urban, S., Knoop, E.V., Cag, N., Krass, P., Grun, S., et al. (2005) Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology 129: 234245.
  • Graham, D.R., Chertova, E., Hilburn, J.M., Arthur, L.O., and Hildreth, J.E. (2003) Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts. J Virol 77: 82378248.
  • Greenwood, A.I., Pan, J., Mills, T.T., Nagle, J.F., Epand, R.M., and Tristram-Nagle, S. (2008) CRAC motif peptide of the HIV-1 gp41 protein thins SOPC membranes and interacts with cholesterol. Biochim Biophys Acta 1778: 11201130.
  • Gripon, P., Le Seyec, J., Rumin, S., and Guguen-Guillouzo, C. (1995) Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 213: 292299.
  • Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., et al. (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA 99: 1565515660.
  • Horie, M., Tsuchiya, Y., Hayashi, M., Iida, Y., Iwasawa, Y., Nagata, Y., et al. (1990) NB-598: a potent competitive inhibitor of squalene epoxidase. J Biol Chem 265: 1807518078.
  • Huovila, A.P., Eder, A.M., and Fuller, S.D. (1992) Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment. J Cell Biol 118: 13051320.
  • Imhoff, H., Von Messling, V., Herrler, G., and Haas, L. (2007) Canine distemper virus infection requires cholesterol in the viral envelope. J Virol 81: 41584165.
  • Jursch, C.A., Gerlich, W.H., Glebe, D., Schaefer, S., Marie, O., and Thraenhart, O. (2002) Molecular approaches to validate disinfectants against human hepatitis B virus. Med Microbiol Immunol (Berl) 190: 189197.
  • Köck, J., Nassal, M., MacNelly, S., Baumert, T.F., Blum, H.E., and Von Weizsacker, F. (2001) Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J Virol 75: 50845089.
  • Ladner, S.K., Otto, M.J., Barker, C.S., Zaifert, K., Wang, G.H., Guo, J.T., et al. (1997) Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother 41: 17151720.
  • Lambert, C., Doring, T., and Prange, R. (2007) Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin. J Virol 81: 90509060.
  • Lawrence, J.C., Saslowsky, D.E., Edwardson, J.M., and Henderson, R.M. (2003) Real-time analysis of the effects of cholesterol on lipid raft behavior using atomic force microscopy. Biophys J 84: 18271832.
  • Leistner, C.M., Gruen-Bernhard, S., and Glebe, D. (2008) Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell Microbiol 10: 122133.
  • Lin, Y.L., Shiao, M.S., Mettling, C., and Chou, C.K. (2003) Cholesterol requirement of hepatitis B surface antigen (HBsAg) secretion. Virology 314: 253260.
  • Lu, X., Xiong, Y., and Silver, J. (2002) Asymmetric requirement for cholesterol in receptor-bearing but not envelope-bearing membranes for fusion mediated by ecotropic murine leukemia virus. J Virol 76: 67016709.
  • Mangold, C.M., and Streeck, R.E. (1993) Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J Virol 67: 45884597.
  • Marsh, M., and Helenius, A. (2006) Virus entry: open sesame. Cell 124: 729740.
  • Matzno, S., Yamauchi, T., Gohda, M., Ishida, N., Katsuura, K., Hanasaki, Y., et al. (1997) Inhibition of cholesterol biosynthesis by squalene epoxidase inhibitor avoids apoptotic cell death in L6 myoblasts. J Lipid Res 38: 16391648.
  • Van Meer, G., Voelker, D.R., and Feigenson, G.W. (2008) Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9: 112124.
  • Nguyen, D.H., Giri, B., Collins, G., and Taub, D.D. (2005) Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. Exp Cell Res 304: 559569.
  • Ohtani, Y., Irie, T., Uekama, K., Fukunaga, K., and Pitha, J. (1989) Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes. Eur J Biochem 186: 1722.
  • Parton, R.G., Joggerst, B., and Simons, K. (1994) Regulated internalization of caveolae. J Cell Biol 127: 11991215.
  • Pelkmans, L., Kartenbeck, J., and Helenius, A. (2001) Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 3: 473483.
  • Pelkmans, L., Puntener, D., and Helenius, A. (2002) Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296: 535539.
  • Persing, D.H., Varmus, H.E., and Ganem, D. (1987) The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid. J Virol 61: 16721677.
  • Petersen, J., Dandri, M., Mier, W., Lutgehetmann, M., Volz, T., Von Weizsacker, F., et al. (2008) Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol 26: 335341.
  • Pietiainen, V., Marjomaki, V., Upla, P., Pelkmans, L., Helenius, A., and Hyypia, T. (2004) Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II, and signaling events. Mol Biol Cell 15: 49114925.
  • Saldanha, J., Gerlich, W., Lelie, N., Dawson, P., Heermann, K., and Heath, A. (2001) An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 80: 6371.
  • Schaefer, S. (2007) Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13: 1421.
  • Schulze, A., Gripon, P., and Urban, S. (2007) Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 46: 17591768.
  • Seitz, S., Urban, S., Antoni, C., and Bottcher, B. (2007) Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions. EMBO J 26: 41604167.
  • Sun, D., and Nassal, M. (2006) Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus. J Hepatol 45: 636645.
  • Sun, X., and Whittaker, G.R. (2003) Role for influenza virus envelope cholesterol in virus entry and infection. J Virol 77: 1254312551.
  • Teissier, E., and Pecheur, E.I. (2007) Lipids as modulators of membrane fusion mediated by viral fusion proteins. Eur Biophys J 36: 887899.
  • Ugawa, T., Kakuta, H., Moritani, H., Matsuda, K., Ishihara, T., Yamaguchi, M., et al. (2000) YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species. Br J Pharmacol 131: 6370.
  • Vincent, N., Genin, C., and Malvoisin, E. (2002) Identification of a conserved domain of the HIV-1 transmembrane protein gp41 which interacts with cholesteryl groups. Biochim Biophys Acta 1567: 157164.
  • Walter, E., Keist, R., Niederost, B., Pult, I., and Blum, H.E. (1996) Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 24: 15.
  • Wounderlich, G., and Bruss, V. (1996) Characterization of early hepatitis B virus surface protein oligomers. Arch Virol 141: 11911205.
  • Xu, X., and London, E. (2000) The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation. Biochemistry 39: 843849.
  • Zidovetzki, R., and Levitan, I. (2007) Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta 1768: 13111324.